Toggle navigation
Menu
About Us
Investment Strategy
Team
Portfolio
News
Contact Us
Limited Partners
Portfolio
Elusys Therapeutics
Develops antibody-based therapies to treat infectious diseases.
Pine Brook, NJ
Contact:
Ron Eastman
www.elusys.com
Formerly Known As: E-Site Therapeutics
Related News
Elusys Awarded Additional $16 Million To Complete Development of Lyophilized Form of Anthim
Elusys Therapeutics Presents Efficacy Results and Other Key Findings on ETI-204 Anthrax Anti-Toxin
Elusys Awarded Additional $14.5Million Under Existing US Government Contracts
Elusys Awarded Additional $50.2 Million Under Existing U.S. Government Contract To Support ETI-204